NCT06441136 Characterizing the Impact of Presbyphonia on Social Interaction
| NCT ID | NCT06441136 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Matthew R. Hoffman |
| Condition | Presbyphonia |
| Study Type | INTERVENTIONAL |
| Enrollment | 25 participants |
| Start Date | 2025-01-10 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 25 participants in total. It began in 2025-01-10 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to determine if presbyphonia, or voice disorder caused by age-related change in the larynx, is associated with change in social interaction. This proposal investigates the impact of voice impairment in older adults on social interaction, loneliness, social disconnectedness, and depression. A series of questionnaires, voice assessments, and interviews will be performed to improve our understanding of how voice disorders affect older adults and how treatment of voice impairment with voice therapy may improve quality of life.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of presbyphonia with findings of presbylaryngis on videostroboscopy, with findings of bilateral true vocal fold atrophy and normal vocal fold motion bilaterally * Able to complete all questionnaires and voice assessment tasks * Normal to mild hearing loss in aided condition (with hearing aids) Exclusion Criteria: * Liquid dysphagia or pneumonia in the last year * Vocal fold lesion/scar/motion impairment * Neurologic disorder affecting the voice * Montreal cognitive assessment score \<26 or \<25 if 12 or fewer years of formal education
Contact & Investigator
Matthew R Hoffman, MD, PhD
PRINCIPAL INVESTIGATOR
University of Iowa
Frequently Asked Questions
Who can join the NCT06441136 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Presbyphonia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06441136 currently recruiting?
Yes, NCT06441136 is actively recruiting participants. Contact the research team at matthew-r-hoffman@uiowa.edu for enrollment information.
Where is the NCT06441136 trial being conducted?
This trial is being conducted at Iowa City, United States.
Who is sponsoring the NCT06441136 clinical trial?
NCT06441136 is sponsored by Matthew R. Hoffman. The principal investigator is Matthew R Hoffman, MD, PhD at University of Iowa. The trial plans to enroll 25 participants.